Bedside Therapeutic Monitoring of β-Lactam Levels in Newborns, Children and Adolescents Admitted to Intensive Care. (MON4STRAT)
Bedside Therapeutic Monitoring of β-Lactam Levels in Newborns, Children and Adolescents Admitted to Intensive Care: Study of a Pharmacokinetics Monitoring Method.
Sponsor: European Commission
Terminated
insufficient inclusions
A NA clinical study on Intensive Care Unit Syndrome, this trial is terminated or withdrawn. The trial is conducted by European Commission and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2023 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jun 2022 — Feb 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jun 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — Sep 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- European Commission
- University Hospital, Lille
For direct contact, visit the study record on ClinicalTrials.gov .